(Q38427860)

3 September 2017

Immunohistochemical detection of XIAP in melanoma (English)

1 reference

3 September 2017

1 reference

Patrick O M Emanuel

1

1 reference

3 September 2017

Robert G Phelps

2

1 reference

3 September 2017

Adarsh Mudgil

3

1 reference

3 September 2017

Michail Shafir

4

1 reference

3 September 2017

David E Burstein

5

1 reference

3 September 2017

1 March 2008

1 reference

Journal of Cutaneous Pathology

3 September 2017

1 reference

3 September 2017

35

1 reference

3 September 2017

3

1 reference

3 September 2017

292-297

1 reference

Phase 2 trial of Allovectin-7 in advanced metastatic melanoma

3 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

XAF1 expression is significantly reduced in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

Recent advances in the care of the patient with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0560.2007.00798.X

10.1111/J.1600-0560.2007.00798.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference